1 / 6

Reasons To Hold PharmEasy Unlisted Shares For Long Term before Its IPO

Reason to Hold PharmEasy Unlisted Shares For Long Term Before its IPO<br><br>PharmEasy is a big name in the healthcare and e-commerce industry, seamlessly blending convenience with essential medical services. PharmEasy connects consumers with a wide range of pharmaceutical and healthcare products, revolutionizing the way people access medicines. I know all of you are eager to know details about PharmEasy IPO & Angel Investors are especially eager to know about PharmEasy share price but before covering that.

ankursingh2626
Download Presentation

Reasons To Hold PharmEasy Unlisted Shares For Long Term before Its IPO

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Reason to Hold PharmEasy Unlisted Shares For Long Term Before its IPO PharmEasy is a big name in the healthcare and e-commerce industry, seamlessly blending convenience with essential medical services. PharmEasy connects consumers with a wide range of pharmaceutical and healthcare products, revolutionizing the way people access medicines. I know all of you are eager to know details about PharmEasy IPO & Angel Investors are especially eager to know about PharmEasy share price but before covering that, we would like to dive in detail about why holding Pharmeasy shares in the long term would be beneficial for you as investors. Pharmeasy has 2 USPs- First, it has a user-friendly interface and secondly, a commitment to delivering genuine medications. Due to the above 2 USPs, PharmEasy has become a go-to destination for individuals seeking a hassle-free solution to their healthcare needs. Pharmeasy is playing a critical role in bridging the gap between traditional pharmacies and the digital age pharmacies, commonly known as e-

  2. pharmacies. PharmEasy offers a diverse range of medicines, wellness products, and diagnostic services, all available at the click of a button. Emerging as a major player in the healthcare sector, PharmEasy's innovative strategies and forward- looking perspective have attracted recognition and funding. With the potential to shape the future of medical accessibility, PharmEasy continues to make strides toward enhancing the well-being of individuals and communities. Let’s take a closer look at Pharmeasy’s performance & compare it to its industry peers: Let’s also take a look at how the Retail Pharmaceutical market has been growing in the past few years & how e-pharmacy market growth is getting assisted directly due to the rise of the Retail Pharmacy market.

  3. If you are considering holding PharmEasy unlisted shares for the long term ahead of its IPO, there are several potential reasons to consider: 1.Market Potential: PharmEasy operates in the healthcare and pharmaceutical sector. The healthcare sector tends to be resilient even during economic downturns like covid, making it a potentially stable investment. According to data presented on its website, Pharmeasy has 25 million registered users on its website. A major spurt was seen during Covid-19 when people started preferring online orders & home deliveries of medicines. 2. E-commerce and Healthcare Integration: PharmEasy's business model involves the integration of e- commerce with healthcare, allowing consumers to order medicines and healthcare products online. This

  4. ongoing trend of digitization in healthcare could position the company well for long-term growth. As of FY21, Pharmeasy has enabled 8.8 million orders, facilitating 2.4 million transacting customers. 3. Changing Consumer Behavior: The COVID-19 pandemic has accelerated the adoption of online platforms for various services, including healthcare. If this trend continues, PharmEasy could benefit from a shift in consumer behavior towards digital healthcare solutions. 4. Potential for Disruption: PharmEasy's approach of simplifying and streamlining the process of obtaining medicines could disrupt traditional pharmacy retail models. If the company is able to successfully execute its strategy, it could potentially capture a significant market share. Another area where Pharmeasy can boost its long-term growth could be from expanding its services beyond its current offerings, such as telemedicine, diagnostic services, or other healthcare-related services. 5. Strong Backing and Partnerships: If PharmEasy has secured significant funding, partnerships, or collaborations with established players in the healthcare or technology industry, this could indicate a strong foundation for future growth. 6. Track Record and Leadership: The track record of the company's leadership, along with the company’s ability to adapt to changing market conditions and execute its business plans, can significantly influence its long-term growth prospects. 7. Financial Performance: Analyze the company's financials, including revenue growth, profitability, and debt levels. The company has been striving forward to reduce it’s expenses which has been evident by the fact that the company has rationalized its workforce in 2022.

  5. Off late there have been reports of the company looking to raise funds at a 90% market down rate. The objective being stated is to pay off the debt worth 285 Mn$ they took for the acquisition of Thyrocare. The deal worth Rs. 4556 Cr. added pressure to its debt obligations. The Manipal Group has taken interest in investing Rs. 1800 Cr. for an 18% share in API Holdings, PharmEasy’s parent company. Manipal Group has been typing to rapidly expand its footprints in the healthcare space. Manipal Group has taken several initiatives like Health Insurance, Manipal Hospitals chain etc. & through Pharmeasy they hope to expand in the digital healthcare space. Pharmeasy management on the other hand would like to use these funds to pay off their interest in addition to expand their presence probably in the insurance tech. & expand their customer base. All being said & done, PharmEasy’s ability to successfully raise funds at a reduced valuation will be an opportune moment for the company. This may push the company to make organizational changes including management changes. Talking about Financial performances, we should also explore PharmEasy’s financials: Now that we have covered financials, let’s also explore how is PharmEasy performing in comparison to its industry peer:

  6. From the above 2 charts, we can infer that although PharmEasy has a lower market cap. In comparison to its peer Medplus Health Services but it earned more revenue in comparison to Medplus. Now that we have covered aspects of PharmEasy in detail, I am sure all of you would be eager to know about PharmEasy share price & PharmEasy IPO plans. PharmEasy is exclusively available on the Planify platform for just Rs. 15 per share. Investors can gain exponential returns in the future by investing right now. As far as PharmEasy IPO is concerned, PharmEasy is expected to launch its IPO within this financial year. So this is the best & appropriate time for investors to purchase shares of PharmEasy. Source: - Click Here...

More Related